CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Pennsylvania Governor Calls On State Lawmakers To Legalize Weed

Pennsylvania Governor Josh Shapiro this week called on state lawmakers to legalize and regulate recreational marijuana, saying “It’s time to catch up” with neighboring states that have already taken the step. The governor made his plea on Tuesday during an annual budget address to unveil a $48.3 billion spending plan for the state. “I ask you to come together and send to my desk a bill that legalizes marijuana,” Shapiro told state lawmakers in his address. “But that bill should ensure the industry is regulated and taxed responsibly.” Although the Democratic governor’s budget proposal does not include a specific cannabis legalization plan, it does call on lawmakers to pass a 20% tax on recreational marijuana. The proposal assumes a January 2025 start date for adult-use cannabis sales and estimates that the state would bring in $14.8 million in tax revenue during the first year. Shapiro added that he expects Pennsylvania’s taxes on recreational marijuana to increase to approximately $250 million per year once the regulated industry is firmly established. “We’re losing out on an industry that, once fully implemented, would bring in more than $250 million in annual revenue,” Shapiro said. “And our failure to legalize and regulate this only fuels the black market and drains much-needed resources for law enforcement. It’s time to catch up.” In a written explanation of the $48.3 billion state budget, Shapiro administration officials wrote that some tax revenue from the regulated adult-use cannabis industry should be used for “restorative justice initiatives” to address decades of inequities in the enforcement of marijuana prohibition laws. Among the initiatives, the governor specifically called on lawmakers to pass legislation to expunge the records of those convicted of possession of small amounts of marijuana. Additional funds from the state’s adult-use cannabis program would go to the Department of Agriculture and the Pennsylvania State Police. The remaining revenue would be directed to the state’s general fund. In his address, the governor noted that legalizing adult-use cannabis is supported by a majority of Pennsylvania voters and that five out of six of the Keystone State’s neighbors have already ended the prohibition of marijuana for adults. “Last year, 57 percent of voters in Ohio supported an initiative to legalize recreational marijuana,” Shapiro said. “And now, Ohio, New York, New Jersey, Delaware, and Maryland – practically all of our neighbors – have legalized marijuana.” Ben Kovler, Founder, CEO and chairman at Green Thumb Industries, a multistate cannabis company that operates 18 RISE medical marijuana dispensaries in Pennsylvania, praised Shapiro’s plan to legalize adult-use cannabis. “We applaud Pennsylvania Governor Josh Shapiro for prioritizing adult-use cannabis legalization this year, including a clear, definitive launch date for sales. This call for change signals continued progress in the Northeast toward ending Prohibition 2.0 and the devastating impact it has inflicted on communities,” Kovler said in a statement to High Times. “The team at Green Thumb is ready to support the people of Pennsylvania on their journey to well-being by providing access to safe, high-quality cannabis.” Pennsylvania legalized the medicinal use of cannabis in 2016 with the passage of the Medical Marijuana Act. Under the state program, patients with one or more specified serious medical conditions are allowed to purchase and use medical marijuana. Qualifying conditions for the use of medical marijuana in Pennsylvania include cancer, epilepsy, inflammatory bowel disease, multiple sclerosis, post-traumatic stress disorder, terminal illness and others. A total of 134 licensed medical marijuana dispensaries were in operation as of last year, according to state data. Since the program’s inception, more than 1.3 million patients have been certified as medical marijuana patients in Pennsylvania, Spotlight PA reported in December. Legalizing recreational marijuana is popular with some lawmakers in Pennsylvania, especially among Democrats. In December, Democratic Senator Sharif Street and Senator Camera Bartolotta, a Republican, introduced bipartisan legislation to legalize adult-use cannabis. Getting the bill through the Pennsylvania Senate, however, may prove difficult. Senator Kim Ward, the Senate majority leader, has said she will not support the legalization of recreational marijuana until the federal government ends cannabis prohibition, according to a report from PA Spotlight.

https://hightimes.com/

Mary Jones Cannabis Bringing Its Soda, Edibles to Canada

Canada’s THC-infused beverage market is about to get more crowded. Jones Soda, the beloved soft drink company known for its quirky flavors, said on Tuesday that the arm of its cannabis business, Mary Jones, “has been approved to operate in Ontario, Canada, with additional provinces to follow.”  “Starting with their THC-infused beverages, the products are currently slated for Ontario availability in Q1 24,” the company said in a press release. Jones is eyeing an additional expansion into other cannabis categories within the Canadian market in collaboration with Tilray Brands, the Canadian cannabis company. The company said in the press release that Tilray handles its manufacturing and distribution in Canada. “Jones was originally founded in Vancouver, BC. Canada and Tilray are a natural fit for our first international expansion for Mary Jones following the incredible success we’ve had in our U.S. markets,” David Knight, CEO of Jones Soda, said in a statement on Tuesday. “Canada’s recreational cannabis sales increased $466.1M CAD in July, up 1.9 % from June this year. We’re looking forward to bringing Mary Jones to Canada’s THC retailers and consumers.” Blair MacNeil, President of Tilray Canada, said that the company is “excited to partner with Mary Jones and to produce their one of a kind beverages at our state-of-the-art London, Ontario facility.”  “The Mary Jones brand has seen enormous success in the United States and we look forward to being a part of their rapid growth in Canada,” MacNeil said.  Jones will “launch in Ontario with its 10MG THC-sodas in a variety of Famous Jones flavors, including Berry Lemonade, Boot Rear (Root Beer) And Col.Ahhhhh (Cola), uniquely labeled for Canadian cannabis packaging and naming requirements,” the press release said.  “The sodas use the same pure cane sugar recipe as mainline Jones, adapted for cannabis. Cannabis consumers in Canada can enjoy Mary Jones THC-infused sodas alone, mixed in craft cocktails, floats and much more,” the press release continued. “Mary Jones is also exploring future expansion into other cannabis categories in the Canadian market, bringing the beverage flavors into other product formats.” The cannabis firm Green Hedge “will support sales and field marketing in Canada for Mary Jones,” according to the press release. “Infused Beverages are growing at a rapid pace in Canada and around the world, including an increasing number of consumers who are shifting to it over alcohol,” said Andrew von Teichman, CEO of Green Hedge. “It creates a highly lucrative opportunity specifically for Mary Jones craft sodas and syrups. Cannabis consumers in Canada are going to love Mary Jones!” For Tilray, Tuesday’s announcement marks another significant development within its beverage portfolio. Last year, Tilray acquired eight beer and beverage brands in a deal with Anheuser-Busch.  Tilray CEO and chairman Irwin D. Simon said at the time that the deal with Anheuser-Busch “both solidifies our national leadership position and share in the U.S. craft brewing market and marks a major step forward in our diversification strategy.”  “We are excited to work with the teams behind these iconic brands that command great consumer loyalty and have a history of delivering strong award-winning products with tremendous growth opportunities. Tilray is fully committed to invest in and champion the future of the U.S. craft beer industry by fueling new innovation that excites and further accelerates the growth of its consumer base,” Simon said in a statement. The deal gave Tilray a number of notable brands, including Shock Top, Breckenridge Brewery and Blue Point Brewing Company. It also included 10 Barrel Brewing Company, Redhook Brewery, Widmer Brothers Brewing, Square Mile Cider Company, and HiBall Energy. In his statement at the time, Simon said the move gave Tilray “national distribution to coveted markets across the U.S. and internationally.”  “In a matter of three years, Tilray has solidified its leadership position in the craft beer industry, and we fully intend to be that change agent that reinvigorates the sector. Upon federal cannabis legalization, we expect to leverage our leadership position, wide distribution network and portfolio of beloved beverage and wellness brands to include THC-based products and maximize all commercial opportunities,” Simon said. In 2020, Tilray engineered a similar deal, acquiring craft beer company Montauk Brewing. “Tilray Brands continues to strengthen our U.S. footprint and operations through investments in and growing our portfolio of leading lifestyle CPG brands that resonate powerfully with consumers,” Simon said at the time. “Montauk Brewing is an iconic brand with leading market share and distribution in the northeast. Tilray Brands intends to leverage SweetWater’s existing nationwide infrastructure and Montauk Brewing’s northeast influence to significantly expand our distribution network and drive profitable growth in our beverage-alcohol segment. This distribution network is part of Tilray’s strategy to leverage our growing portfolio of U.S. CPG brands and ultimately to launch THC-based product adjacencies upon federal legalization in the U.S.”

https://hightimes.com/

Magic Mushrooms Busts Up Amid Renewed Interest in Psychedelics

Seizures of magic mushrooms have spiked over recent years as interest in the potential benefits of psychedelics including psilocybin rose, according to the results of a new study. The study, which was conducted by researchers at NYU Langone Health, New York City, and the University of Florida, Gainesville, was published this week by the journal Drug and Alcohol Dependence. The study found that more than 1,800 pounds of psilocybin mushrooms were seized by law enforcement agencies across the nation in 2022, up from the nearly 500 pounds confiscated in 2017. The researchers found that the greatest number of seizures occurred in the Midwest (36.0%), followed by the West (33.5%).  The West led with the most mushrooms seized by weight over the six years covered by the study, with 4,109 pounds or 42.6% of the total, followed closely by the South with 4,039 pounds or 41.8% of the shrooms confiscated. Seizures by weight peaked in 2021 when law enforcement agencies seized about 3,400 pounds of psilocybin mushrooms. The authors of the study, which was funded by the National Institute on Drug Abuse (NIDA), believe the increase in seizures suggests that there has been a boost in the supply of psilocybin mushrooms nationwide. “What I think the results indicate is that shroom availability has likely been increasing,” Joseph Palamar, an epidemiologist at NYU Langone Health and the main author of the new study, told NPR. Nora D. Volkow, M.D., the director of NIDA, noted that the research was conducted at a time when the potential mental health benefits of psilocybin mushrooms had received significant attention. Numerous studies have shown that psilocybin may be an effective treatment for mental health conditions including anxiety, depression, substance use disorders and post-traumatic stress disorder (PTSD).  “We are in the middle of a rapidly evolving cultural, media, and legal landscape when it comes to psychedelics, and we need data to help shape informed and appropriate public health strategies,” Volkow, who was not involved in the study, said in a statement from NIDA. “Moving forward, we must continue to track data on the availability of psychedelics, patterns in use, and associated health effects to guide efforts in promoting accurate education and reducing potential harms among people who do plan to use psychedelic drugs.” Although the research into the benefits of psilocybin is promising, the psychedelic drug has not been approved by the U.S. Food and Drug Administration. Volkow is concerned that the progress in studying the drug will lead people to self-medicate with psilocybin. “Psychedelic drugs have been promoted as a potential cure for many health conditions without adequate research to support these claims,” Volkow said. “There are people who are very desperate for mental health care, and there are businesses that are very eager to make money by marketing substances as treatments or cures.” The authors of the new study believe that all the buzz about the research into psychedelics has resulted in changing attitudes surrounding psilocybin. “All of the positive coverage of psychedelics might be introducing the idea of using them to a new population that never really considered using them before,” Palamar told The New York Times. Dr. Joshua S. Siegel, a psychiatrist at Washington University in St. Louis who was not involved in the study, said that the new research is “an important part of the bigger picture of where we are headed as a nation” with psychedelics.  “It’s important to understand what’s happening in terms of the health care side of things,” Siegel added. “It’s important to understand what’s happening recreationally and legally.” Although psilocybin mushrooms are still illegal at the federal level except for authorized research, the legal status of shrooms is changing at the state and local levels. Many municipalities across the country have adopted policies to effectively decriminalize magic mushrooms, and both Oregon and Colorado have passed legislation to decriminalize psilocybin and legalize supervised therapeutic use of the drug. “The greatest overall weight in seizures was out west,” Palamar said. “And I don’t think it’s coincidental that that’s where a lot of the more liberal policies are starting to take effect.” Although psilocybin therapy can have dramatic and long-lasting mental health benefits, there are risks associated with using the drug that should be considered. Siegel explained that while psychedelics are less deadly and have a lower risk of addiction than many other drugs, psilocybin can be destabilizing, particularly for people with serious mental health conditions. “People can partly or completely lose touch with reality and behave in irrational and potentially dangerous ways,” said Siegel. Officials note that the risk can be great, with the most dangerous cases potentially resulting in psychosis that can lead to impulsive behavior including suicide. “We need to be aware that the use of these drugs comes at a certain cost,” said Volkow.

https://hightimes.com/

Grateful Dead Break Billboard Record Almost 30 Years After Disbanding

The Grateful Dead have made Billboard chart history despite not being a band for nearly 30 years, with the greatest number of top 40 albums to ever make the Billboard 200. According to Billboard, the release of Dave’s Picks, Volume 49: Frost Amphitheatre, Stanford U., Palo Alto, CA (4/27/85 & 4/28/85) debuted at number 25 on the charts making the total number of top 40 releases in the Dead’s repertoire at 59, surpassing both Frank Sinatra and Elvis Presley who were previously tied for the record at 58. “Dave’s Picks” is a series of live recordings of old Grateful Dead shows put together by archivist David Lemiex, who will celebrate his 25’th year of working with the band this year. These albums are responsible for 41 of the 59 top 40 debuts and have all been released well after the 1995 death of Grateful Dead frontman Jerry Garcia in 1995. The latest release in this series sold 21,000 of the 25,000 printed album units which were all exclusively sold through Official Grateful Dead channels. “This could be the most unlikely and unexpected record in music history, and is a testament to a few things,” Lemieux said in a press release. “First and foremost is the exceptional and consistent quality of the Grateful Dead’s more than 2,000 live shows. On the heels of this is the loyalty and passion of the many Dead Heads who have made this record possible. And to top it off, the Grateful Dead have a partnership with Rhino that ensures these many album releases are produced with care, love, and respect for both the band’s music and legacy, and the Dead Heads themselves.” Even decades after disbanding the Grateful Dead has maintained a powerful presence among their fan base which seems to grow larger every day. Dead-themed merchandise and products stretch into every sector of the economy, especially among the emerging legal cannabis community. “Dead and Company,” a Grateful Dead cover/spin-off band formed by three former Dead members and others including John Mayer have been credited with spreading Grateful Dead music to a younger audience. Their tour last year saw over 840,000 attendees with over 120,000 at the final San Francisco show alone. “It’s an honor and privilege to work for this community, and our aim is to keep building on this record by delivering the quality of recordings Dead Heads have come to expect for many years ahead,” Lemieux said. “It is truly remarkable to witness the Grateful Dead’s enduring legacy and profound impact.” Mark Pinkus, President of Rhino, reinforced Lemieux’s sentiments in a statement, intimating that the success of these album releases is proof of the real, tangible influence the Dead perpetuated with their music.  “Their music and culture transcend time, and this groundbreaking achievement is a testament to their ongoing influence. Rhino is honored to continue to share their meaningful and magical music with Dead Heads, both old and new,” Pinkus said. Bernie Cahill, Founding Partner of Activist Artists Management and manager of the Grateful Dead said in a statement that the release of Dave’s Picks Volume 49 was a reminder that the Grateful Dead reinvented the way live shows were performed and remembered, as is evidenced by the immense popularity of the live recordings among their fanbase. “This remarkable achievement speaks not only to the genius and vision of the Grateful Dead, it is also a reminder of their truly epic live shows that reinterpreted their great American songbook every single time they took the stage! Simply put, this is another incredible milestone for a band who has never compromised, and has always done everything on their own terms,” Cahill said. Dead and Company’s final tour was supposed to be in 2023 but they announced at the end of the tour they likely were not done, shortly thereafter announcing a string of 24 shows at the Las Vegas sphere (which currently boasts a giant deadhead image on its outer shell) from May 16 to July 16 of 2024. Dave’s Picks Vol. 50 (Palladium, New York City – 5/3/77) is slated for release in April.

https://hightimes.com/

New Jersey Introduces Digital MMJ Cards With No Registration, Renewal Fees

As New Jersey approaches the two-year anniversary of its recreational cannabis market launch this April and adult-use revenue continues to rise, regulators recently announced a new incentive for residents to secure their medical cards. The New Jersey Cannabis Regulatory Commission (NJ-CRC) announced last week that signup and renewal for its new digital medical cards will be free. According to the commission, the new digital cards will begin rolling out in a few weeks and were introduced to prioritize patient accessibility and convenience. The digital cards can be presented on a mobile device, eliminating the risk of losing or damaging a physical card while also enhancing accessibility, the commission says. Those who would still like a physical medical card are still in for a bargain, as the NJ-CRC also recently reduced its physical registration fees to $10 — they will not be required to pay again until renewal two years later, which is also a $10 fee. The entire announcement touches on a number of other topics related to New Jersey medical cannabis, with the last header hitting on “Satisfaction Among Program Participants.” It notes a recent survey, conducted by the commission, that found less than 9% of 1,000 surveyed patients said they were unsatisfied with the service they received after contacting Patient Services at the NJ-CRC. “While many respondents shared concerns about the health care provider fees, product prices, and product availability, more than half said they participate in the program to enjoy the lower price they get from regular patient discounts and not having to pay state taxes, and to have access to the strains and products available only to patients,” the commission states in the announcement. It also encourages readers to look out for dates for medical cannabis program registration clinics, which are set to be held across New Jersey in the coming months. Looking at New Jersey cannabis sales trends, the reduction in registration and renewal fees may not come as a shock. New York similarly waived its $50 medical cannabis fee in 2022, the year after it legalized recreational cannabis. And as New Jersey’s recreational cannabis market has continued to blossom, boosting overall sales numbers, its medical sales are gradually declining. In April 2022, when recreational sales launched in New Jersey, there were 128,548 total patients in the state. That number in January 2024 was only 88,670, approximately a 31% decrease in less than two years. While medical sales numbers for 2023 Q4 are not yet available, looking at year-over-year comparisons of Q3 also provides some context for just how stark this change is. Medical sales for 2022 Q3 came to about $61.1 million, while 2023 Q3 was less than half that amount at approximately $29.2 million.  Conversely, recreational sales year-over-year for the same periods increased from approximately $177.7 million to $206.1 million, for 2022 and 2023’s third quarters respectively. While the NJ-CRC did not make any explicit mentions of sales trends and the decline of medical cannabis sales numbers, it’s likely that these moves were made in part to encourage more residents to take advantage of the state’s medical cannabis program. As regions introduce their own legal recreational cannabis markets, allowing access for anyone over 21 years old with a valid ID, consumers in legal cannabis states often wonder about the need for a medical card.  One of the main perks for many is avoiding the taxes levied on recreational products, as mentioned by the commission in their announcement.  In New Jersey, recreational cannabis products are subject to the standard 6.625% sales tax, along with the Social Equity Excise Fee which changes based on the average price of cannabis — as of Jan. 1, 2024, the fee was updated to $1.24 per ounce. Municipalities can also charge a 2% transfer fee on cannabis sales that occur within their borders. These taxes may not seem extreme given the additional taxes in some other states — Washington State has the highest cannabis taxes in the continental U.S. with its 37% excise tax, for example. While the tax rates may not be the highest, New Jersey infamously has some of the most expensive recreational cannabis in the country. Aside from the tax relief, medical programs tend to have cheaper pricing along with specialized products, higher dosage options and more.  Whether these efforts will actually reverse New Jersey’s medical cannabis market trends remains to be seen; the decline in medical sales and program enrollment numbers tends to be a recurring theme in medical-only states that legalize recreational cannabis.

https://hightimes.com/

Cannabis Business Presence Increasing on the Colorado Tourism Office Website

A report from Westword pointed out that the Colorado Tourism Office (CTO) has recently begun to feature information regarding a few cannabis businesses on its website. Westword spoke with licensed cannabis party bus business owner, Sarah Woodson, confirming that the CTO contacted her last year about her The Cannabis Experience. According to CBS News, her business was the nation’s first licensed cannabis consumption bus as of February 2023. The CTO website features some of Colorado’s best places to visit and check out, from snow-related activities, white water rafting, hot springs, dining recommendations, and an updated calendar of events on the front page. As of Feb. 5, the front page doesn’t showcase any cannabis-related businesses or activities. A quick search yields just a few cannabis-related business profiles, which includes both The Cannabis Experience, Colorado Cannabis Tours, Speak Easy Vape Lounge & Cannabis Club, Ambers Alchemy, and a 420 friendly Bed and Breakfast called Arrowhead Manor. It also includes various advice articles about disposing of cannabis when leaving the state, tips for safe consumption, and more, in addition to a few older search results where the landing pages do not work or have been removed. The profiles don’t feature a date of publishing, so it’s unclear how long they’ve been up on the website. Westword points out that Speak Easy Vape Lounge & Cannabis Club opened with a temporary local permit that expired this year and is now closed. Arrowhead Manor does not hold a hospitality license, so it must conduct business as a private venue. As of July 2023, the CTO announced that in 2022, the state collected $27.7 billion in travel spending within the state from approximately 90 million tourists. This annual spending was a $5.6 billion increase, or 25% increase from revenue generated in 2021 ($22.1 billion), with an additional 5.8 million visitors more than those who visited in 2021. The press release included a variety of other facts and data regarding its growing tourism industry, which was shared from the Colorado Travel Impacts 2022 (Dean Runyan Associates) and Colorado Travel Year Report 2022 (Longwoods International). Neither of these reports mentioned cannabis. The CTO is a division under the Governor’s Office of Economic Development and International Trade (OEDIT), that is managed by the Colorado Tourism Board, which includes 11 people appointed by both the governor and four Colorado legislators. As a government-run agency, cannabis-related hospitality opportunities and events might be tricky to advertise. Currently, public cannabis consumption is illegal, so tourists seeking legal cannabis-friendly tourism must do their own research to find private businesses that cater to that interest. One of the people who was formerly on the CTO board of directors, cannabis dispensary owner Wanda James, stated that the CTO began allowing certain cannabis businesses to advertise on the Colorado tourism website after a state hospitality law (which was passed in 2019) took effect on Jan. 1, 2020. James added that progress on including cannabis on the website decreased after former director Cathy Ritter was let go by OEDIT. Advertising a business on the Colorado tourism website is free, but interested business owners must apply on the website. “To get a free listing on Colorado.com, start by filling out the form below. Note: To appear on Colorado.com, listings must be tourism related and have a physical address in Colorado,” the application form states. Toward the bottom, it requires a short description of the business, “so that we can verify you are part of the tourism industry.” Westword obtained a statement from CTO spokesperson Hayes Norris, who explained that The Cannabis Experience is very much a welcome part of the industry worth advertising. “The Cannabis Experience is a great example of that, as they offer a range of immersive cannabis tours and experiences,” said Norris.”…there have not been any formal changes to colorado.com business rules regarding licensed hospitality businesses and cannabis.” While the CTO is not yet ready to begin the task of featuring more cannabis-themed venues and activities, organizations such as the Cannabis Travel Association International are more focused on putting the spotlight on cannabis-friendly destinations both in the U.S. and other international locations as well. While Colorado was the first to implement recreational cannabis legalization back in 2014, many other states are building up their cannabis consumption laws and business as well. In New Jersey, cannabis consumption lounges were only recently approved by the New Jersey Cannabis Regulatory Commission (CRC) last month. “New Jersey’s cannabis industry is well on its way to being a billion-dollar industry, and consumption areas will likely bolster that—fostering a communal experience for those 21 and older around cannabis in a regulated and secure space,” said CRC executive director Jeff Brown. In Nevada, the most batch of consumption lounge licenses was issued in November 2023, while a number of other license holders are eyeing 2024 for the year they hope they’ll satisfy all of the requirements to open. The Las Vegas, Nevada-based Planet 13 announced in November last year that it was eyeing an April 2024 opening, and in December 2023 it confirmed that the consumption lounge would also share a space with the Las Vegas SuperStore to Koolsville Tattoo Shop.

https://hightimes.com/

Announcing the High Times Cannabis Cup SoCal: People’s Choice Edition 2024

Are you ready for the heat that will define Southern California in 2024? The High Times Cannabis Cup SoCal: People’s Choice Edition is back in town, and the offerings of cannabis flower and products are set to redefine the selection. It’s an adult-use competition celebrating some of the best cannabis products in the region—one of the largest cannabis markets of its kind on the planet. Product submissions will be accepted from cannabis retailers and businesses beginning April 1-3. Judge Kits go on-sale beginning on April 8. Judges will have nearly two months to let the Once that takes place, Judges will be expected to narrow down the winners by June 2.  Judges fill out scorecards, indicating how each submission measured up. Judges assess how each strain looks, tastes, smells, effects, and burnability on a scale of one to 10. An email is automatically sent to confirm each time a strain or product review is submitted. The emails also serve as a placement point to know which strains have already been completed. These scorecards ultimately determine who wins. Finally, the winners of this highly-anticipated event will be announced via a livestream on June 16. The original High Times Cannabis Cup SoCal was first introduced as an in-person event that was held between 2015-2019. The pandemic changed things up, shifting a move into People’s Choice events which put the power in the hands of the people, in this case, the fine people of Southern California. This High Times Cannabis Cup event offers consumers the unique opportunity to experience the finest cannabis available to consumers—relative to the specific market of Southern California. For retailers, this is more than just a competition—it’s a chance to elevate products on a  For cannabis brands that wish to submit products for this year’s competition, please refer to the following rules to bring your product to a global stage and compete for the esteemed High Times Cannabis Cup. Please also adhere to the following entry requirements. Flower submissions will be 1-gram samples. We will not accept any 3.5-gram entries. Pre-Rolls and infused pre-roll samples will also have the following requirements. Pre-Rolls will be capped at 2 grams of flower-only each; Infused pre-rolls will be capped at 3-gram flower equivalency or 1 gram concentrate equivalency each. For concentrates and vape pens, we will accept 5-gram samples. We will not accept any 1-gram entries—and keep in mind that batteries are required for carts. Edibles) samples will have a 100 mg THC maximum amount. Sublinguals, capsules, tinctures and topical samples will be capped with a 500mg THC max. Competitors should note the entry fees are dependent upon how many products they submit. While one entry is $250, and two entries will be priced at $100 per entry, both non-refundable, and submissions of three or more entries is a $100 refundable deposit per entry held, which is refunded when all entries are successfully submitted.  Potential sponsors for this year’s High Times Cannabis Cup SoCal: People’s Choice Edition 2024 will have all entry fees waived. We also offer multiple tiers of sponsorship, including General, Bronze, Silver, and Presenting Sponsorships. That sums up the details of our event this year but check out our High Times Cannabis Cup website to view all of the details. For a sense of what to expect, check out who shined and who took home awards at the past several years of SoCal Cannabis Cup events. Last year’s winners highlighted known and respected brands including Fig Farms, Team Elite Genetics, Papa’s Select, Top Shelf Cultivation, Maven Genetics. In 2022, we were also amazed with what we saw at the 2022 SoCal: People’s Choice Edition. That year, winners such as Top Shelf Cultivation’s Whoa Si Whoa, Sense’s Pink Certz Flower, Wizard Trees’s Studio 54, and Team Elite Genetics’s Pearadise Flower took home many titles. You can expect to see more surprises this year. Cannabis Cups were first conceived in 1987 by former High Times editor Steven Hager, and slowly spread out from The Netherlands to legal jurisdiction across the world. Join the ranks of the elite and put your product to the ultimate test. May the best brands prevail!

https://hightimes.com/

DEA Celebrates War on Drugs in Cringey Post During Black History Month

On Feb. 1, the official X account of The Drug Enforcement Administration (DEA) posted a photo of former President Richard Nixon and a caption meant to celebrate the legacy of the War on Drugs, but the comment section didn’t go as planned. Making things worse, the DEA posted it on the first day of Black History Month, which is especially ironic given that cannabis laws were unfairly enforced mostly on Black and brown Americans. “On Dec. 14, 1970, at the White House, the International Narcotic Enforcement Officers’ Association presented President Nixon with a ‘certificate of special honor’ in recognition of the outstanding loyalty and contribution to support narcotic law enforcement,” the post reads. The post was marked with a tag for Throwback Thursday, #TBT. A chorus of rebuttals swiftly followed as people asked essentially the same question: Is the drug war something we should be celebrating? People like Cat Packer—the director of drug markets and legal regulation at the Drug Policy Alliance and former executive director of Los Angeles’ Department of Cannabis Regulation—immediately explained why the post is fundamentally wrong on multiple levels. “On the first day of Black History Month 2024 the Biden Administration’s DEA is celebrating President Nixon—this is the same agency responsible for marijuana scheduling,” Packer wrote. Black Americans are arrested for violating cannabis possession laws at nearly four times the rates of white Americans, even though both demographics consume pot at relatively the same rates, the National Organization for the Reform of Marijuana Laws (NORML) notes. This racial disparity in cannabis arrests is much worse in certain areas. For instance in New York, a 2021 analysis of cannabis-related arrests in New York City’s five boroughs during 2020 reported that people of color made up 94 percent of people who were arrested. If laws cannot be enforced equally on the people, after decades of attempts, then why enforce them at all? “It is an incredible affront to do Nixon today. You should remove this post. Nixon did more to harm the black community than any other President in the 20th century. And he did it with the War On Drugs,” Erik Radle, CEO of The Miller Ad Agency wrote in response. Nixon’s own administration now admits that the War on Drugs—particularly the war on cannabis—was intentionally used as a weapon to target Black Americans and anti-Vietnam War demonstrators. John Ehrlichman, who worked under Nixon and was a Watergate co-conspirator, blew the whistle in Harper’s Magazine in 2016—fully admitting the racist intentions of the Nixon administration in launching the War on Drugs. “You want to know what this was really all about?” Ehrlichman asked. “The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and black people. You understand what I’m saying? We knew we couldn’t make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.” Nixon unceremoniously resigned from office under Section 1 of the 25th Amendment on August 9, 1974 when his impeachment materialized and became imminent. Throughout the history of America, only Andrew Jackson, Bill Clinton, and Donald Trump (two times) were impeached in the House, however only Nixon was completely removed from office. Other presidents may have picked up in Nixon’s footsteps. The Atlantic ran an expose in 2019 on recently uncovered audio, captured in October 1971, alleging that then-California Governor Ronald Reagan held a damning conversation with Nixon before ascending to the Oval Office. The audio transcript shows how Reagan singled out and disparaged Black Americans before his presidency. Famously, Reagan was the president who launched the War on Drugs 2.0 along with First Lady Nancy Reagan, the “Just Say No” era when the federal government ramped up attacks on cannabis consumers and drug users. The recent post on Feb. 1 shows the level of denial in the DEA about the success of the War on Drugs and how out of touch they are with the public. It wasn’t a success: Overdose deaths continue to hit all-time highs, billions of dollars are wasted, and the drug laws aren’t enforced fairly on Black and brown Americans.

https://hightimes.com/

Humboldt Weed Grower To Pay $750,000 for Environmental Violations

A Humboldt County cannabis grower will pay at least $750,000 to settle a dispute with state water and wildlife agencies over alleged environmental violations at a 435-acre cultivation site in California’s famed Emerald Triangle. In the settlement agreement, licensed weed grower Joshua Sweet and his companies, The Hills LLC and Shadow Light Ranch LLC, admitted to violations of state water regulations over a period of several years.  “It is critical for all cannabis cultivators to be environmentally responsible and protect California’s water supply and water quality,” Taro Murano, program manager for the State Water Board’s Division of Water Rights cannabis enforcement section, said in a statement from the California Department of Fish and Wildlife (CDFW). “Sweet chose to operate his business while ignoring regulations designed to protect the environment. He must now remediate the environmental damage he caused and pay a significant penalty. No one should get a business advantage by ignoring the law and harming the environment.” The settlement calls for Sweet to pay $1.75 million for the violations, which include illegally diverting and collecting water from unnamed tributaries of the South Fork Eel River that cross the property. According to the settlement terms, $1 million of the fine was suspended, but Sweet will be responsible for paying the additional $1 million if remediations to the property are not completed as agreed. The settlement cites several violations, including building an unpermitted pond on a waterway to collect water for irrigating cannabis plants. Other violations include the destruction of wetland habitats and stream channels, converting oak woodland to cannabis cultivation and failure to work with state and local officials to satisfy permitting requirements. Yvonne West, director of the State Water Resources Control Board’s office of enforcement, said that Sweet and his companies did not have the authority to divert water on the property and use it for cannabis cultivation. According to an email from the water board to nonprofit news outlet CalMatters, Sweet took about 16.2 acre-feet of water, approximately enough to supply about 49 households for a year, for a total of three ponds on the property between 2017 and 2020. “This case represents years of hard work by dedicated staff to remediate damage to streambed channels, wetland habitat and oak woodlands,” said Nathaniel Arnold, acting chief of law enforcement for CDFW. “The settlement also speaks volumes to the egregious nature of this case and should send a strong message to those working outside of state regulations to cultivate cannabis. Our natural resources deserve to be respected.” Included in the settlement agreement is a $500,000 payment for water rights violations, a record penalty for such a violation in the state of California. The defendants are also required to remove unpermitted ponds and restore wetlands and waterways as part of the agreement. Sweet believes that the fines are unfair and excessive and that the case could have been handled differently. “If the full penalty and remediation costs were due today it would take everything I own,” Sweet said in a statement to CalMatters. “Although I will follow through with my end of the settlement, I do not believe this is fair or just, and I believe I have already suffered way too much,” Sweet said in the emailed statement.  “Even during our court-mandated settlement conference, they were asked why they would go after a small independent businessman with these type of enormous fines usually reserved for huge corporations that destroy ecosystems,” he added. But state and local officials defended the settlement, saying it is justified by the actions taken at the property. “The ordered penalties are modest given the scope of damage, the length of time the site has been left unremediated and considering the unjust enrichment or benefit to Mr. Sweet from running a business for several years without going through the necessary permitting process,” said Jeremy Valverde, assistant chief counsel at the California Department of Fish and Wildlife, in a statement emailed to CalMatters. Joshua Curtis, the North Coast Regional Water Quality Control Board’s assistant executive officer, said that Sweet and his businesses “for years resisted our attempts to cooperatively work on restoration and recovery of those resources, leaving formal enforcement as our only option.” “This was an ongoing use by Mr. Sweet and the penalties are over an approximately four-year period for unauthorized diversion and use of water to support cultivation,” said West of the water board. “Five hundred dollars a day, multiple violations over a four-year period, does really add up. And then again we did have the additional types of violations at play here as well.”

https://hightimes.com/

Germany’s Coalition Government Reaches Deal on Weed Legalization

The groups that form Germany’s coalition government struck a deal last week on cannabis legalization, setting the stage for the new law to take effect in the spring.  Now, the proposal will be considered by the country’s parliament, with a vote expected later this month. Zeit, a German publication, reported last week that the “government coalition made up of the SPD, Greens and FDP has agreed on the details of the legalization of cannabis,” and that the “law could come into force on April 1st, but must first be approved by the Bundestag and Bundesrat.”  According to the outlet, Karl Lauterbach, Germany’s federal health minister, “is aiming for approval in parliament in the week from February 19th to 23rd.” In a post on X last week, Lauterbach hailed the agreement by the groups within the coalition. “The fight against the black market, decriminalization and better protection of minors will come as announced. The previous drug policy has failed, a new beginning,” Lauterbach said. The agreement keeps the country on course that the so-called “Traffic Light coalition” laid out late last year.  In November, the SPD, Greens and FDP said they had reached a breakthrough in their negotiations of the new cannabis law.  “The #Cannabis law is coming! Finally: We are finally ending the failed ban policy! After intensive negotiations, there is now a law that focuses on youth and health protection, ends criminalization and is practical,” the Green Party’s spokesperson Kirsten Kappert-Gonther said in a post on social media at the time. According to Forbes, the “path to legalization in Germany has encountered several hurdles,” including the coalition government having to “revise its plan, which initially involved the sale of cannabis, as it risked breaching EU laws.” Forbes reported that the coalition also “confronted criticism from opposition parties seeking to obstruct the proposed legislation,” as well as “internal dissent within the government, particularly from the SPD, emerged regarding the details of the bill.” The outlet Legal Tribune Online said that the agreement last week signaled that “resistance from the ranks of the SPD parliamentary group against the Cannabis Act (CanG) has apparently been overcome.” Late last year, Legal Tribune Online reported that “health politician Dirk Heidenblut MdB, who is responsible for the issue of cannabis in the SPD parliamentary group, announced over the weekend via social media that the final reading of the Cannabis Act (CanG), which was actually planned for the last week of the year, was taking place. does not come about.”  “The reason: The leadership of his SPD parliamentary group expressed concerns about the set-up. The avowed legalization friend explained in a video that he could not understand this, but the implementation would now be postponed until next year. Heidenblut did not want to reveal any further details,” the outlet reported at the time. “The short-term veto of the SPD parliamentary group against the final resolution surprised not only the so-called cannabis community, but also the coalition partners.” Kappert-Gonther said at the time that it was “extremely unfortunate that cannabis is not on the agenda so far,” and that passage of the reform “would have been possible.” But last week’s agreement by the parties indicates that those disagreements have been resolved, and that Germany is now set to enter a new era of cannabis legalization. In a statement, the leaders of the coalition said that the “regulations are a real milestone for a modern drug policy that strengthens prevention and improves health, child and youth protection,” as quoted by Legal Tribune Online. According to Forbes, the agreement “clears the path for the legalization of cannabis for personal use, aligning with the impending vote,” and that, absent any additional delays, “Germany is poised to become the third European Union member state to legalize cannabis for personal use, following Malta and Luxembourg.” “For the government coalition, the legalization of cannabis for personal use marks a significant milestone in modern drug policy, emphasizing prevention and improving health and child and youth protection,” Forbes reported. “However, the proposed legislation, introduced last year by Federal Health Minister Karl Lauterbach, may undergo additional slight revisions to address concerns raised by the SPD, potentially involving the expansion and acceleration of monitoring and reporting obligations related to the illicit market.” Forbes said that lawmakers “recently revised the bill to ease restrictions opposed by advocates and supporters in the Bundestag,” with changes including “raising home possession limits and eliminating the possibility of jail time for slightly exceeding the possession limit.” “The government coalition also plans to introduce a complementary measure establishing pilot programs for commercial sales, set to be revealed after submission to the European Commission,” Forbes said, adding that, if the proposal passes the parliament in the next two months as expected, the ban on pot will be lifted by April 1, and that adults will be able to “grow cannabis at home and possess small quantities, while cannabis clubs will be allowed from July 1.”

https://hightimes.com/

Travis Barker Talks Moving into Adult-Use Space, Touring, and Barker Canna Co.

Today Travis Barker—the lauded drummer of recently reunited Blink-182, Transplants, Goldfinger, and more—announced the launch of Barker Canna Co., after founding CBD brand Barker Wellness last April. The concept is to provide quality cannabis products that are capable of promoting both creativity and wellness, and the rigors of touring pushed Barker into the potent side of the cannabis space.  Barker Canna Co. initially launched in California at The Syndicate dispensary locations with plans to expand throughout the state. The company will likely expand in other states with legal cannabis markets in 2024. The Barker Canna Co. will roll out everything from live rosin and full-gram vapes, gummies, and mini-infused pre-rolls. The vape hardware for the live rosin and full-gram vape products was developed by Jupiter Research, known experts in the field.  Hemp-derived products are regulated entirely differently from adult-use cannabis products in California. So what in fact prompted Barker’s decision to move from hemp-derived CBD products to state-legal potent cannabis? “The decision to expand from hemp-derived CBD products to state-legal potent cannabis was driven by a strategic response to the evolving cannabis landscape and consumer preferences,” Barker tells High Times.  Things have been good lately for the drummer: Last month, Barker kicked off the Emmys—something he’s been waiting “all his life” to do, performing Phil Collins’s “In the Air Tonight” along with an entourage of performers, Anthony Anderson and a choir from Compton, California. Blink-182’s “All the Small Things” just hit one billion streams on Spotify, joining the “Billion Club.” The band’s last album One More Time was released on Oct. 20, 2023, prompting an extended world tour. Cannabis became the answer to a life constantly on the road, he explained, and part of it was about his own recovery process. The momentous, four-leg Blink-182 reunion world tour will take Barker from Madrid to Melbourne by the time it’s over. This means nearly 100 shows, over 40 in North America and dozens more in Europe, Latin American, and Oceania—imagine the toll that level of touring would take on a person’s body. “Initially seeking balance amid a chaotic lifestyle, cannabis, especially edibles, became my recovery go-to,” Barker says. “For me personally, it’s about aligning mentally and physically with my chosen lifestyle. Today, my relationship with cannabis is sophisticated, focusing on balance, creativity, well-being, and positive vibes. Barker Canna Co. is born from this journey, offering quality products to share what I’ve learned.”  The brand features items like vegan and gluten-free Mini Peanut Butter Cups or hard-hitting Live Rosin All-In-One Vapes. But one thing that stood out to us are the Barkies—packs of five mini pre-rolls dipped in kief. These come in strains like Rainbow OG Popsicle or Blackberry Diesel. He plans on expanding Barker Canna Co. products to other state-legal cannabis markets in the near future. It’s a state-by-state process different from selling hemp-derived products legal under the 2018 Farm Bill. “California is our starting point, laying down the groundwork for our brand,” Barker says. We plan to expand throughout the state and other legalized states in 2024 so stay tuned. We’re keeping it flexible and ready for whatever comes our way.”  Occasionally High Times staff goes to The Syndicate—some locations having a false library wall for a pretty badass retro speakeasy aesthetic. The velvet-lined walls take you back 100 years to the Roaring ‘20s. It’s a vibe if you’ve never been to one. “I’ve been going to The Syndicate for years,” Barker recalls. “They have an incredible team and amazing product selection. As a result, they have become my go-to trustworthy cannabis retailer. Their vibe is really cool and I always have the best experience going into their stores.” Barker and Blink-182 are currently on the Australia leg of their tour, so there’s a lot more work to do, and a lot more recovery. Barker was only about 17 and a known stoner in school when Blink-182 formed, long before fame, marrying a Kardashian, and reality television. And the last time the original line-up of Blink-182 performed was in 2014—a decade ago. So what will he do to prepare for the tour? “My prep work for touring looks a lot different than it used to!” Barker, 48, laughs. “I try to stay as active as possible and make sure I really take care of myself and recover when I have down time. Using the Barker Wellness and Barker Canna Co. products helps with this journey—whether it’s to alleviate muscle pain or spark creativity. Maintaining stamina and strength is crucial for what I do so I’m constantly practicing so I can perform at my best.” Visit a The Syndicate location throughout California to find Barker Canna Co., developed in part by Barker.

https://hightimes.com/

LGBTQ+ Advocates Call Out LCB in Recent Raids at Gay Bars

A group of gay bar owners and LGBTQ+ advocates recently released a joint statement regarding recent “visits,” which they describe as raids, conducted by the Washington State Liquor and Cannabis Control Board (LCB) at their businesses in the Capitol Hill neighborhood. The LCB told bar owners on Jan. 26 and 27 that law enforcement observed violations of the law often called the “lewd conduct law,” which requires employees and patrons to clothe specific parts of their bodies. A coalition of these advocates release a statement on Instagram on Jan. 29 about the raids, including Joey Burgess (The Cuff Complex and Queer/Bar), Keth Christensen (The Seattle Eagle), Kevin Kauer (Massive), Dan Savage (podcast host and author), Terry Miller (founder of the It Gets Better Project alongside his husband, Savage), and Kurt Olivo, and called on advocates to attend an LCB meeting on Jan. 30. “We are issuing this statement to express our concern over recent events targeting gay men. Specifically, unjust raids were conducted by the Joint Enforcement Team (JET) and the Liquor Control Board at several historic gay bars, by extension threatening all active LGBTQ nightlife venues,” the statement said. “Our coalition consists of establishments that provide safe spaces for diverse and marginalized communities to express themselves through love, music, dance, and art. The recent raids have disrupted these operations and undermined trust and security within our community.” The statement continued to explain that none of the venues within the coalition have ever previously been cited for alcohol or violent offenses, and at most, citations related to an individual’s clothing, such as “being shirtless or wearing a jockstrap.” Furthermore, raids on LGBTQ+ businesses have historically persecuted marginalized communities in their safe spaces, and the most recent events cause the relationship between the LGBTQ+ community and law enforcement to be challenged. In response, the coalition statement called for an investigation into the LCB raids. “Our coalition remains committed to fostering positive relations with all stakeholders, emphasizing the need for mutual respect and an understanding of the unique challenges faced by gay, and by extension, LGBTQ+ community as a whole,” the statement concluded. “This statement serves as a call for justice, equality, and the protection of the rights and dignity of our community members.” The coalition, alongside other residents and advocates, attended an LCB meeting on Jan. 30, where members of the community called out the LCB. “These were raids. Stop calling them visits. If everyone in a bar leaves when you show up, 10 of you in uniform with flashlights, they are not experiencing your presence as a social call,” Savage said. “The message sent was if they are raiding gay bars in Seattle, if they are harassing gay men for being shirtless in gay bars in Seattle, we are winning—the bigots are winning.” According to King5, the LCB also had individuals taking photographs in the bars to obtain evidence of “lewd conduct.” The LCB investigators didn’t make their visit or their identity known to business owners or patrons at the time. “Taking pictures without consent of gay men and then posting those pictures as evidence is immoral,” said an unnamed speaker at the meeting. Savage described the LCB raid as a violation, rather than a “visit,” and explained that the photos are subject to the Public Disclosure laws which means they will be released to the public once the investigation has been completed. “Not all the men who go to the Eagle are out of the closet in all areas of their lives. Men could lose their jobs or homes once these photographs are released,” wrote Miller on Instagram on Jan. 31. “LCB officers knew these photos would become a part of the public record. LCB officers knew each photo they took had the potential to ‘cause harm to the depicted person.’” At the meeting, LCB Director David Postman stated that the violations were recorded during the usual enforcement duties conducted by LCB officers. Postman also acknowledged the LCB’s history with the LGBTQ+ community in the past, and he and two other board members agreed to prevent incidents like the raids from happening again. Washington State law, also referred to as the “lewd conduct law,” prohibits such conduct for any business that holds a liquor license, including employees or patrons being unclothed and exposing parts of the body “to view any portion of the breast below the top of the areola or of any portion of the pubic hair, anus, cleft of the buttocks, vulva, or genitals,” among many other examples. King5 wrote that the law was intended to prevent strip clubs from serving alcohol, but Postman commented that changes to the law are being reconsidered in the Washington legislature. “The lewd conduct law, it’s problematic, just talking about my personal point of view here,” Postman said. However, Postman also added that even if the law is archaic, they must continue to enforce it until changes are made. “When there’s laws on the books, it’s really hard to just say ‘Well, we’ve decided not to enforce that one’—the lawmakers, the legislature doesn’t like that, and for good reason,” said Postman. “I can tell you; there is no crackdown on lewd conduct right now, there is no crackdown on gay clubs, there’s no crackdown on clubs in Seattle or anywhere else. We’re doing our normal business here.” LCB board member Jim Vollendroff also spoke at the meeting, ensuring members of the LGBTQ+ community that they will seek a way to prevent it from happening in the future. Likewise, Seattle Mayor Bruce Harrell also issued a statement about the LCB inspections, acknowledging community concerns. “Under my administration, we will not target people or communities based on their sexuality,” Harrell said. “We understand concerns raised by the community based on a perception of violating this principle.” Last year in July, a new cannabis ordinance took effect, which offers labor protections for employees, which “will help provide a stable workplace, stronger workforce, and contribute to a better overall economy for Seattle.”

https://hightimes.com/

Drug Maker Unveils Experimental Drug as Opioid Alternative

A pharmaceutical company unveiled an experimental new drug that is being touted as a less dangerous alternative to opioids. To date, few drugs have demonstrated enough power to manage higher levels of pain often associated with post-surgery recovery. WXYZ Detroit, an ABC affiliate, reports that Vertex Pharmaceuticals said Tuesday the drug’s use in late-stage clinical trials resulted in “clinically meaningful reduction in pain,” without many of the risks associated with opioids. The new drug is called VX-548 and it’s showing promise in early stages. Two trials demonstrated that patients who recently came out of surgery who received Vertex’s new drug had statistically significant pain relief. Phase 2 trial results were published Dec. 13, 2023, noting its effects on painful diabetic peripheral neuropathy. Researchers in a third trial observed a wider range of pain-related conditions. Phase 3 trial results were published on Jan. 30, 2024 and showed “clinically meaningful reduction in pain from baseline in both the abdominoplasty and bunionectomy randomized controlled trials,” as well as many other surgery-related conditions.  Participants who used the drug for up to 14 days also noted positive results, with over 83% of patients saying VX-548 was “good” to “excellent” at managing pain.   Vertex noted VX-548 was “safe and well-tolerated in all three studies,” but it failed to work better than hydrocodone bitartrate/acetaminophen, aka Vicodin. The National Library of Medicine notes that pain is a complex phenomenon, and that one type of painkiller won’t work for all situations. Vertex plans to submit a New Drug Application to the U.S. Food and Drug Administration (FDA) by mid-2024 regarding VX-548’s treatment of moderate-to-severe acute pain. Vertex’s Phase 1-3 trials move the company closer to gaining approvals from the FDA. If they are successful, it could  provide people in the U.S. with another pain treatment option. The vast majority of drug overdoses in the U.S. continues to be dominated by opioids. And to make things worse, the confusion over addiction leads to making it harder for patients who actually need opioids to get them prescribed. According to The National Center for Health Statistics (NCHS) under the U.S. Centers for Disease Control and Prevention, drug overdose deaths rose from 2019 to 2021 with over 106,000 drug overdose deaths reported in 2021. Deaths involving synthetic opioids—primarily fentanyl and excluding methadone—continued its death march with 70,601 overdose deaths reported in 2021. Fentanyl in particular kills 150 Americans per day. Many other attempts to develop alternatives to opioids that effectively dull pain, but they typically fail. If Vertex’s drug is ultimately deemed to be safe, it could introduce a new class of acute pain medicine for the first time in about 20 years, Dr. Jessica Oswald told WXYZ. “As a physician treating patients suffering from pain for many years, I know firsthand the critical need for new, efficacious and safe treatment options,” Oswald said. “The Phase 3 safety and efficacy across the three studies are impressive and demonstrate VX-548’s potential to change the paradigm of pain management.” Opioids kill more Americans than car crashes or gun violence. An alternative to effective, but highly dangerous opioids, some of which having the power to stop breathing, is sorely needed. Bayer introduced heroin in 1898 and called it a “wonder drug” meant to be less addictive than morphine, which was ravaging America at the time with drug addicts. It wasn’t until over 10 years later that an army of heroin addicts emerged. Cannabis itself has been explored as an opioid alternative, but it works in very different ways. One study is taking a closer look at the specific holistic effects that both medical cannabis and opioids provide to get more insight on the efficacy of each substance as it pertains to chronic pain management. The recent study, “The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain,” was conducted by a team of researchers from Åbo Akademi University, who looked into the effects of medical cannabis and opioids for chronic pain treatment. Published in the Journal of Cannabis Research, the study aimed to take a closer look at how effective medical cannabis is compared to traditional opioids in treating chronic pain, as cannabis use for symptom management has become increasingly more common in recent years. Results suggested that opioids and cannabis are both “equally efficacious” at mitigating pain intensity in patients with chronic pain, while cannabis offered more “holistic” relief in improving sleep, focus and emotional wellbeing. Vertex Pharmaceuticals could help provide a safer alternative compared to typical opioids that have created an epidemic of drug overdoses in the U.S.

https://hightimes.com/

Massachusetts Cannabis Business Owners’ Lawsuit Against the U.S. Government Continues

The saga continues for four Massachusetts-based business owners who filed a lawsuit against the U.S. Justice Department in an attempt to overturn cannabis prohibition. The plaintiffs include owners of Canna Provisions, Inc., Gyasi Sellers, Wiseacre Farm, Inc., and Verano Holdings Corp., who are represented by David Boies and Josh Schiller of Bois Schiller Flexner LLP. The lawsuit was first issued in October 2023, and used the results of a court case from 2005, Gonzales v. Raich, to showcase how federal prohibition of cannabis is outdated. “The federal criminal prohibition on intrastate marijuana remains in place, an unjustified vestige of a long-abandoned policy,” the lawsuit states. “This unjustified intrusion of federal power harms Plaintiffs, threatens the communities they serve, and lacks any rational purpose.” According to a news report published by The Boston Globe, U.S. Attorney General Merrick Garland filed a motion to dismiss the case on Jan. 23, stating that the plaintiffs have no standing on which to sue, and have presented no evidence that prohibition has caused them injury (such as being arrested or prosecuted). The motion stated that “Even if the court were free to disregard Raich ’s holdings (it is not), Plaintiff’s attacks on that holding are unpersuasive,” that the “Plaintiffs lack standing to challenge the CSA [Controlled Substances Act],” and “Courts have consistently, and correctly, held that no fundamental right exists to distribute, possess, or use marijuana.” The Boston Globe noted that the Department of Justice declined to comment, as of Jan. 29. In defense of the business owners, Schiller described how there is evidence that the longstanding illegality of cannabis from a federal standpoint is “well-established.” Schiller cited examples such as cannabis businesses being heavily taxed, forced to pay insurance premiums, cannot take credit cards as a form of payment, and usually pay a higher price for rent or mortgages, “Almost like they are illegal businesses.” James Smith, of Smith, Costello, & Crawford, commented on the lawsuit and told The Boston Globe that winning a case like this one is a “high hill to climb.” Even still, Smith described Massachusetts’ regulatory framework for legalization as “pretty pristine.” The federal government has yet to make a move on federal legalization and has made no constructive decisions regarding major industry issues, such as banking. Smith added that with a lack of action from the federal government, that leaves state legislators to act—and courts are waiting for them to do so. Another comment was provided by Boston University professor and author, Jay Wexler, who told the news outlet that if legislators lose interest in regulating cannabis federally, then expecting the federal government to take on the role of cannabis business in all states “falls apart.” Wexler also stated that this current case could eventually reach the Supreme Court. “These are cases where plaintiffs are aiming for the Supreme Court because there are precedents,” said Wexler. “It’s pretty unlikely that lower courts will feel comfortable agreeing with the plaintiffs.” Schiller estimated that the lawsuit could take two years to reach a conclusion. But one of the plaintiffs, Gyasi Sellers, who owns a delivery service called Treevit, explained that it’s worth the wait. The opportunity to freely and legally take credit cards as a form of payment would improve his entire business, making delivery quicker and also maintaining a safe work environment for employees. Sellers described how prohibition would be “like getting our training wheels taken off, or our handcuffs taken off, depending on how you want to look at it. It’d be nice to say our fate is actually in our hands, and we have the ability to reach our true potential.” The support for putting an end to prohibition continues to grow. Following the recommendation to move cannabis from a Schedule I to a Schedule III substance by the U.S. Department of Health and Human Services, the industry eagerly awaits the decision of the Drug Enforcement Administration. Meanwhile, multiple House representatives and Senators are calling out to President Biden to make a move as well. In a High Times exclusive interview, New York Senator Kristen Gillibrand called for an end to prohibition. “Studies show that legalizing marijuana could help reduce violence in international drug trafficking and generate billions of dollars for the economy,” Gillibrand said. “The vast majority of Americans agree that marijuana should be legalized—that’s why I’m calling on the Attorney General and the Drug Enforcement Administration to swiftly deschedule marijuana from the Controlled Substances Act.” Many predict that rescheduling cannabis could give Biden a huge boost in the upcoming election later this year. A survey conducted by Lake Research Partner showed that Biden could benefit from an 11% boost from younger voters (based on the opinions of 900 voters used in the survey, spread out across the U.S.).

https://hightimes.com/

Yet Another Study Shows Ketamine To Be An Effective Treatment For Depression

Ketamine may be an effective treatment for severe depression, according to the results of a recently published clinical trial. The research, which was published in the peer-reviewed Journal of Affective Disorders, found that participants with major depressive disorder showed a significant improvement in symptoms including suicidality after receiving intravenous ketamine infusion therapy. Major depressive disorder, also called clinical depression, is a mental health disorder characterized by persistent feelings of sadness and a loss of interest, according to information from the Mayo Clinic. The condition affects about 5% of the adult population globally, according to data from the World Health Organization, and can lead to difficulties in all aspects of life including home, work and school.  Depression is often treated with antidepressants and mood stabilizers, but these treatments have shown only limited success. Some patients do not respond to these options at all, while many others fail to achieve remission.  In prior studies, ketamine, which is commonly used as a dissociative anesthetic, has shown promise as a treatment for depression in patients who have not shown improvement with other therapies. The drug’s effects are particularly rapid and have shown the potential to reduce suicidal ideation in subjects with major depressive disorder. The new research was conducted at four leading medical institutions across the United States as part of a larger study to determine blood-based biomarkers of depression treatment response. While the effects of ketamine can be dramatic, it is not well understood who can benefit the most from the drug. With the study, researchers hope to identify blood-based biomarkers to help predict who will benefit the most from ketamine therapy. “The main purpose of the study is to find a blood test that can help predict who will benefit from intravenous ketamine,” study author Sagar V. Parikh, a professor of psychiatry at the University of Michigan, explained to PsyPost. “This first publication looked at whether three infusions were capable of causing remission (it was in 52% of people in less than two weeks, which is wonderful news). We believe that ketamine will be a standard and highly effective treatment for people who don’t respond to traditional antidepressants.” The study was conducted between May 2017 and March 2020 and involved participants from the Mayo Clinic, the University of Michigan, Johns Hopkins University and Pine Rest Christian Mental Health Services in Michigan. To qualify for the study, prospective participants were required to be between the ages of 18 and 65 years old and diagnosed with major depressive disorder or bipolar I or II disorder. Participants also were required to have a history of treatment resistance to traditional antidepressant therapies. Participants who were selected for the research continued taking their existing medications throughout the trial. Researchers monitored the participants using diagnostic tests to assess factors such as depressive symptoms and suicidal ideation. The study participants received a total of three ketamine infusions over 11 days. Each infusion was administered over 40 to 100 minutes, depending on individual responses and concerns for potential side effects. Researchers closely monitored cardiac activity and side effects during treatment. About half (52%) of study participants achieved remission as determined by a marked reduction in their scores on the diagnostic tests. Researchers noted that the rate of remission was significant given the participants’ history of treatment resistance. Participants also showed a marked reduction in suicidal ideation. At the onset of the study, 81% of participants had notable suicidal ideation. Following the ketamine treatment, two-thirds of participants showed a reduction in suicidality of at least 50% as measured by the diagnostic tools. “There is great hope that ketamine is a new and highly effective treatment, and that it might be possible to find a blood test to tell us if ketamine is the right choice for a particular person,” said Parikh. The long-term objective of this line of research is “to find fast and effective treatments for depression, so people don’t have to wait months and use trial and error to find the right treatment.” During or after the infusion treatments, some participants experienced notable side effects, which were monitored using the Ketamine Side Effects Scale. Most side effects, however, had largely subsided after 60 minutes. Researchers recorded only one serious adverse event, an episode of hypoglycemia in a participant with diabetes. “The treatments were extremely well tolerated,” Parikh said. “We also tried to see if even slower infusion would make it more tolerable, and if the speed of infusion (slow at over 100 minutes versus standard over 40 minutes), and found that slower did not have any advantages.” The researchers noted the limitations of the study, including the lack of a control group that would have allowed for comparison to a placebo or alternative treatment. “These are the clinical findings, we are still waiting to publish our reports on various biomarkers found in the blood,” Parikh explained. “Those findings will come out over the next year.”

https://hightimes.com/

Drug Testing Access at Australian Festivals May Have Prevented Past Deaths

It’s already fairly well known that music festivals tend to come with plenty of illicit drug use. The activity is so common at festivals, and in dance scenes as a whole, that organizers and attendees alike are becoming increasingly more equipped to combat potential overdoses through a variety of measures. A new study published in the International Journal of Drug Policy underscores the impact of these harm reduction strategies and consciously incorporating them into events, looking at the amount of drug-related deaths at Australian music festivals, the common trends and what may have helped to prevent them. Moreover, the researchers ultimately confirmed that mobile medical care, drug testing and increased consumer education and awareness could have prevented these largely unintentional deaths. Researchers note the high prevalence of drug use among festival attendees compared to the general population, citing a study finding that 44% of over 5,200 surveyed Australian music festival attendees reported past-month use of illicit drugs. That said, it’s no surprise that more instances of drug use often result in increased cases of drug-related harm. To examine the prevalence of drug-related deaths at Australian music festivals, researchers conducted a descriptive case series study using the National Coronial Information System (NCIS) looking at relevant data between July 2000 and December 2019. The study noted a total of 64 deaths, predominantly males (73.4%) aged in their mid-20s (ranging 15-50 years old). MDMA and alcohol were the most common substances across the study period, reported respectively in 42 (65.6%) and 30 (46.9%) cases and with alcohol co-detected with MDMA in 14 (33.3%) cases.  Deaths were primarily associated with toxicity from MDMA and other stimulants (19 cases), toxicity from other drugs or drug combinations (11 cases) and either natural causes (10 cases) or external injuries (24 cases) in the setting of drug use, like those involving motor vehicle or train collisions or a passenger or driver using drugs. The majority of cases involved unintended harm, with 11 deaths (17.2%) related to intentional self-harm. So, what exactly are the ways to prevent a drug overdose at these events? Authors note that there is limited evidence surrounding the efficacy of specific law enforcement-related approaches. While drug detection dogs have been utilized in Australian festivals for more than two decades, researchers note some research showing this can actually increase risk of drug-related harm. They also mention that this method may “paradoxically increase the risk of overdose,” with attendees potentially leading to festival goers hiding drugs internally or quickly consuming drugs to avoid arrest. There’s drug checking and testing, which allows members of the public to analyze drugs to confirm if they contain any potentially dangerous or unexpected substances and how much of a substance is actually in a given powder, pill, tablet and so on.  Researchers note the body of research finding that this option indeed demonstrates a reduction in drug use and related harm. Combating the notion that people may be more inclined to use drugs with the ability to test them, researchers cite a recent study finding that festival attendees are no more likely to use drugs at festivals whether drug testing is provided or not. Music festivals also tend to have mobile paramedics, peer harm reduction workers, chill-out spaces and may even incorporate specific physical design elements to reduce the risk of drug-related harm. Authors note that in these 64 cases, the most common cause of death was MDMA toxicity. While there are a variety of factors associated with increased risk of adverse effects surrounding MDMA usage, researchers highlight the variability in dose amounts as a key factor. For this study, the average MDMA concentration among the deaths was above a range usually associated with toxicity, showing an opportunity for harm reduction by drug checking and testing. “Drug checking is not merely an analytical process; counsellors are available on-site to discuss analytical results and provide important harm reduction interventions,” researchers write. “This approach is favoured by festival patrons and has resulted in positive outcomes including changing dosing patterns, trust of health providers, and increased drug harm reduction knowledge.” However these services are still in their infancy in Australia, despite being available throughout Europe and North America for a number of decades. “Harm reduction strategies such as roving first aid volunteers, mobile medical care, spaces to rest, hydration stations, and drug checking services, may best address some of the risks associated with illicit drug use at festivals, in addition to increased consumer education and awareness,” authors conclude. “It is important to understand the factors involved in these incidents in order to inform policies around harm reduction and law enforcement at music festivals in future to prevent further deaths.” In an interview with online music magazine and community platform Resident Advisor, co-author Dr. Jennifer Schumann underscored the findings around harm reduction, citing that two in three Austalians support drug checking services along with recommendations from coroners throughout the region to implement these services. “It’s possible that information about the drugs these people were taking, along with harm-reduction advice from drug-checking service counsellors, may have prevented death in some cases in our study,” Schumann said. It’s a particularly relevant topic Down Under, with renewed calls for more safety measures after nine people were hospitalized in January from suspected MDMA overdoses at Melbourne’s Hardmission Festival.

https://hightimes.com/

The Best Ingredient

During any given week, chef Nate Santana, winner of the first episode of Netflix’s Cooked With Cannabis, pushes himself to concoct several new dishes in order to keep things raw and fresh. His dishes are inspired by the hallmarks of Southern hospitality and many other cultural influences. The Palmdale, California native crept up the ladder of professional culinary arts, eventually moving to Los Angeles. He began cooking at Culver City’s award-winning restaurant The Wallace while still a student at The Art Institute of California. At the time it was run by chef Joel Miller, one of his mentors in the art of food. Santana climbed the ranks at The Wallace to executive sous chef and ended up curating the menu there himself. Armed with experience, Santana became the chef de cuisine at New Orleans-themed Preux & Proper—following the lead of chef Sammy Monsour. For those out of the know, Preux & Proper was a Michelin-rated fine restaurant that honed in on the heritage of the South through elements of hospitality, seasonality, sustainability, and craft-level cocktails. It was one of many restaurants, however, that did not survive the pandemic. Santana is currently sous chef at The h.wood Group, where he curates the food for private events, and owner of Dorthy’s Pizza, a private pop-up collective of gourmet pizza delicacies he launched with acclaimed chef Jack Hotchkin. And when I say pizza, I mean pizza with ingredients like boar sausage, Spanish chorizo, balsamic redux, fennel pollen, Fresno pepper jelly and so on—food that you can taste hours later, which is a stoner’s dream. Cannabis is at the core of Santana’s cooking mentality. When cannabis is involved, however, due to legal restraints, the infused dishes are usually served at private events in the form of a pop-up. Fortunately, pop-ups in Los Angeles and New York cater to the high bar set by foodies, as does Santana. A few years ago, before the pandemic, I was blessed to attend two such pop-ups, including an infused private, underground pop-up experience called Cultured, Create + Destroy in the Venice Beach area of Los Angeles, with an exclusive shortlist of cannabis-adjacent journalists and influencers. A large fan leaf adorned my plate at my place sitting, and each guest received a live resin vape pen. The food was infused with locally sourced pot from Los Angeles-based Botafarm Genetics. Botafarm was founded by Jay R., the grandson of a winemaker from Bordeaux, France, and Santana is their go-to chef. My particular menu for the evening included a multi-layered experience including Kumamoto oyster, Botafarm-infused fermented hot sauce—and Jack Herer-derived terpene for the kicker. One of the other choices for the main course was pork loin al pastor, with charred tomatillo pesto, with Botafarm blueberry muffin with a dehydrated pineapple chip. “I think LA is ahead of its time in terms of cuisine,” Santana tells High Times. “The food is really good. There’s just so much culture here. There are a lot of really good chefs here that are pushing the boundaries. I think all of the diversity and culture is good for LA. You could say the same thing about New York.” Santana’s food has a multi-layered taste you can’t exactly describe in words, enhanced by terpenes and the natural herbal taste of cannabis. On Instagram, Santana calls cannabis “the world’s best ingredient.” “I mean, it just is,” Santana says. “Everyone knows it can improve your health, lower stress, improve stimulation. It’s an ingredient I’ll keep using all of my life. It does the same thing for food: the flavors are great. If you can do it right, it can do really good things for food. I personally like the appearance and you can taste the flavor, at least when it’s sourced from really good farms.” He explained that cannabis’s herbal flavor is more useful than common herbs like rosemary or thyme. Cannabis has its own pleasurable taste. “It’s just like smoking, you can really taste the difference when it’s good quality.” Santana explained how he uses the same process to select cannabis that he does when sourcing vegetables locally, from farmer’s markets and other places that have farm-to-table quality foods. Sometimes he wants his guests to taste the weed and sometimes he doesn’t. “It really depends,” he says. “Like any great product, if it’s grown by farmers and tastes great, you really want to highlight that.” Santana won the first episode of Cooked With Cannabis on Netflix, which became available on the streaming service back in 2020, by playing it safe with a grilled burger, which the judges loved. In every episode, there’s a $10,000 dollar prize. (Chef Manuel Mendoza was the final winner of the season.) The chefs were judged by singer-songwriter Kelis and food expert Leather Storrs, joined by Ricki Lake, Mary Lynn Rajskub, singer Elle King, and comedian Jo Koy, and the first episode had a backyard grill theme, which Santana nailed. His professional achievements peaked only to have his world thrown upside-down by the pandemic, as in-person pop-ups were core to his overall persona. “I was on the first episode of the first season,” Santana says. “And I filmed that back in 2019. It’s weird how it seems so far away now. And then in April 2020, everything just got shut down. So it’s a competition show. It was three courses and we had to do infusions, freezer foods, how to do the right dosage. It was fun and I’d do it again.” When the pandemic wreaked havoc on his in-person private pop-up plans, he pivoted to other ventures, including Dorthy’s Pizza, a gourmet pizza pop-up collective, named after his grandmother. Dorthy’s Pizza deep dish cheesy crusts are a wonder to behold, and are cooked with the secrets only Santana knows. Follow and book Santana by visiting his Instagram at @chef_nate_santana and @dorthys_pizza for a “little slice of society.” Recipe by Chef Nate Santana 100 grams of mint 30 grams cilantro 50 grams parsley 2 Fresno peppers 1 shallot 2 tsp lemon zest and juice each 3 tsp Sherry vinegar Salt to taste Pepper to taste Olive oil—enough to bring together 3 tbsp Pot d’Huile infused olive oil Instructions This article was originally published in the December 2023 issue of High Times Magazine.

https://hightimes.com/

Back in the Game

Yelawolf is back in Nashville, Tennessee not long after performing a sold-out show with rapper-turned-country star Jelly Roll in Denver, Colorado. Wolf’s explosive set was a lesson in how all artists should command a stage—he was energetic, engaging, and a little bit enigmatic. Wearing a pair of aviator sunglasses, a black beret, and a leather jacket, the Alabama-born artist doesn’t look like the average MC. The tattoos, leather cuts, and patches make him look more like a Hell’s Angel than a former Shady Records signee. But that’s partly what makes Yelawolf so intriguing. Not to mention his musical versatility is almost otherworldly. Born Michael Wayne Atha in a small town in Alabama, Yelawolf jumped around as a kid but spent the bulk of his childhood in Antioch, Tennessee. He naturally gravitated toward the rebelliousness of skateboarding, punk rock, rock, and hip-hop, which inadvertently shaped Wolf’s future. His entire catalog is an amalgamation of those influences—from 2008’s Stereo: A Hip Hop Tribute to Classic Rock and 2015’s Love Story to 2019’s Trunk Muzik III and his more recent project with Shooter Jennings, 2022’s Sometimes Y. Translated live, it’s clear he was born for the stage. “I’ve never had stage fright,” he tells High Times. “But I was definitely raised around a different type of live performance. I grew up going to underground hip-hop and punk rock shows in Atlanta. My first gangster rap show was Three 6 Mafia and Mystikal, and that was rowdy. I like rowdy. So when we first started doing shows in Atlanta, we had kids that would wear helmets to our shows; it was that crazy. We just kind of made it our thing, at least I did—head-banging, crowd surfing. Then I applied that energy to hip-hop because when I saw Method Man and Redman when I was a kid, I crowd surfed in the pit. Or Beastie Boys, you know.” Armed with that same ethos, Michael Wayne Atha was transformed into Yelawolf in his late teens. His first show was at the 231 Club in Jackson, Alabama, although it was more of an appearance. He shared the stage with 10 other guys and only got to spit a few bars, but that’s where the journey began. For some, the mere thought of performing in front of a crowd is terrifying, but Yelawolf never struggled with that. “I was kind of born with this fearlessness,” he says. “I got on stage when I was 5 years old and sang with my uncle. He held me up to the mic. And my mom raised me around artists. She was dating dudes who were on the road, so being on stage and around buses and artists was kind of normal. But ego supersedes talent. It’ll train you to get better if you just have the balls to go up there and be persistent. Falling down in front of people—I think that’s the key—like literally falling off stage or forgetting a verse or just plain getting booed.” Getting booed isn’t something Yelawolf experiences these days. If anything, his audience is salivating for more by the time his set is over. But for him, it’s off to the next thing, the next city, the next show. Wolf’s punk rock ethos has remained intact since he was a young wolf pup, but the “sex, drugs, and rock ‘n’ roll” lifestyle that so often comes along with a career in music can become cumbersome. Yelawolf has certainly weathered some storms, but he always seems to land on his feet. However, his experiences with drugs and alcohol have altered the way he moves. Although he has the utmost respect for the medicinal benefits cannabis can provide, he can no longer use it. It was only four years ago when he was involuntarily put on a 72-hour psychiatric hold in San Diego or, what he called, “5150’ed.” “They sent me to a padded room and shit, for real,” he remembers. “It was like that Green Day video [‘Basket Case’]. They kept me in there for three days and then I had to go to rehab for a while. I love weed. I wish I could smoke it. I love the smell of it and I love the idea of it, but the therapist I was talking to said I was basically clinically allergic. They said I could smoke a bunch of different strains, but by the time I found one that may or may not fit me, I would be back in the same situation.” Experiencing such a traumatic incident would scare anyone into sobriety—at least for a while. Yelawolf has periods where he doesn’t use anything, but then he’ll drink whiskey or other types of alcohol. But to him, that’s much more manageable.  “You just gotta know yourself,” he says. “You have to really fucking trust your gut. Shit does not affect everybody the same, and that’s a fact. Getting to know yourself…I wouldn’t suggest anybody leaning on medication for what could be a mental health or spiritual health issue that you just need to go figure some shit out by yourself. So that’s what I did. Drinking is something I can measure. I can measure my buzz. I can follow it, and I can take it as far as I want to or not. It’s safer for me than the alternative.” Yelawolf is currently focused on releasing his next rap record, a double album and 180-degree pivot from the project he did with Shooter Jennings. A couple of factors contributed to his decision to jump back in. “After the rock ‘n’ roll record with Shooter, it was so bittersweet to have such, what we considered, a really amazing project with critical acclaim and shit,” he says. “But it was also becoming like a paperweight for me. We had to remove something that was holding it down, but we couldn’t put our finger on it. It became one thing after another. We couldn’t do a show because Shooter isn’t available, or this guy’s doing this or that guy is doing that. I didn’t want to get another band because I already branded them. “That kind of pushed me into doing another record. The other part was like a creative voice. I was itching for hip-hop badly again and frankly, I was inspired, like Kendrick Lamar is doing amazing work right now. I was also inspired by the wack shit. I’m not gonna say names, but I was inspired by the garbage that was coming out. And I was like, ‘Man, I want to put my foot back in the game.’ Then, of course, there were the people who said, ‘Oh, he quit rapping.’ I never said that.” With his hunger for rap at a ravenous level again, Yelawolf hit up his longtime collaborator James Ryan Ho, better known as Grammy Award-winning producer Malay, and fellow producer WLPWR to get to work. But rather than doing one project, Wolf did one with each producer, hence the double LP. “I went and did an album with WLPWR, and I went and did a record with Malay. They were different but vibe wise, they were just so good. We wanted to put them out as a double album instead of stretching it out and dangling the carrot so to speak. We came up with the title War Story because it’s opposite of Love Story.” Yelawolf hasn’t set a release date yet, but the project will live under the Slumerican umbrella. “The album I did with WLPWR is called Trunk Musik Forever and then the other album is called Michael Wayne that I did with Malay, but they’ll be under one package. Michael Wayne is the most honest I’ve ever been. Trunk Musik Forever has some really personal shit, but it’s not a downer. It’s got some really fun records.” This article was originally published in the December 2023 issue of High Times Magazine.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.